Precisis GmbH is headquartered in Heidelberg and specialises in the development of innovative medical devices. Precisis GmbH stands for outstanding success in the realm of device-controlled therapies for the brain.
Our plans for the future
The next crossroads for the company is the start of the study for CE certification for the innovative brain stimulation device EASEE® for the treatment of severe epilepsy in children and adolescents in autumn 2022.
Experiences:
Education:
Medical studies and doctorate, RWTH Aachen
Founding member Healthcare Frauen e.V
Experiences:
Education:
Physikstudium an der Friedrich-Alexander-Universität, Erlangen-Nürnberg
Experiences:
Education:
Diploma Engineering Degree (Dipl.-Ing. FH) Biotechnology, University of Applied Sciences Giessen-Friedberg
Experiences:
Education:
Medical Laboratory Technician
Before a medical technology product becomes available on the open market, it must undergo many laborious technological development steps, and extensive testing and validation procedures. These include both animal studies and studies on sick people.
Precisis conducted the first implantation of its system in 2019 – the ‘first-in-human’ clinical study. Since then, we have developed the perspective of several hundred therapy months and can proudly claim that our initial creative idea has gone on to become a safe and highly effective therapeutic method. The step-by-step, careful and laborious licensing procedure (Medical Device regulation, MDR) is intended primarily to serve patient safety: however, the data evaluation also serves to answer the question whether what may be an expensive innovative therapy should take its place in our health insurance system and be regarded as worthy of reimbursement. We consider ourselves fortunate in that our brain stimulation product is already achieving significant success in people with severe brain disorders.
On September 15, 2022, we received CE certification for our EASEE System for the treatment of adults with focal epilepsy. The next step is now the study in children and adolescents in order to obtain the CE certification here as well.
More than 28 years experience in the Consumer Goods Industry for a leading global Dax 40 company.
Last position as Executive Vice President / Member of the Management Board
Serves today besides others as
Spent more than 20 years in the implantable industry for cardiac and hearing loss products
More than 28 years experience in global leading medical device companies
Broad experience in the Neurology, Cardiology, Urology, Hepatology and Orthopedics field.
Spent 30 years in the medical device industry with 20 years of management experience
15 Years experience as CFO in global technology companies
To date, Precisis has benefited from two BMBF (German Federal Ministry of Education and Research) grant programmes that financially support medical technology innovations. With these grant programmes, the Federal Ministry of Education and Research has indicated its conviction that the medical technology sector represents a highly innovative and fast-growing branch of the health care industry and that technological innovations can not only improve the care of sick individuals but also represent the best economic opportunities for companies. However, the bulk of financing during the high-risk start-up phase of development was carried through private investments.
bmbf.deIn 2021, Precisis and the Australian firm Cochlear Ltd concluded a partnership agreement. The new relationship with Cochlear offers financial benefits for Precisis along with access to Cochlear’s scientific expertise.Cochlear is the world’s leading provider of implantable solutions for people who are hearing- impaired. The firm employs over 4,000 people worldwide and invests more than AUD 180 million annually in research and development. Its products include hearing systems for cochlear implants, bone conduction implants and acoustic implants, which were developed for the treatment of moderate to severe hearing loss. Since 1981, the company has manufactured more than 650,000 implantable devices, which are helping people of all ages to hear in around 180 countries.
cochlear.com
